What is the evidence base for Selank (Intranasal)?

Selank (Intranasal)'s evidence base sits at research level investigational. The references on this page summarise 1 primary publication supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The male physiology interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

What does Selank (Intranasal) stack well with?

For male physiology protocols, Selank (Intranasal) pairs with compounds on complementary pathways: Kisspeptin, Gonadorelin (GnRH), PT-141. These pairings are selected because they engage independent receptor systems from Selank (Intranasal)'s primary mechanism (Same Selank molecule; olfactory pathway bypasses BBB), producing additive or synergistic effects rather than receptor competition.

What is the regulatory status of Selank (Intranasal)?

Selank (Intranasal) regulatory status: Unapproved (Russia approved) in the United States; WADA status not on prohibited list; research level research level investigational. Clinical access for off-label use is via compounded prescription where permissible. International regulatory status varies by jurisdiction. For male hormonal and performance use specifically, the regulatory profile shapes which monitoring and supervision approaches are required.

What is the mechanism of action of Selank (Intranasal)?

Same Selank molecule; olfactory pathway bypasses BBB. For male hormonal and performance applications specifically, the relevant downstream consequence is the cascade from receptor engagement to systemic effect: Same Selank molecule; olfactory pathway bypasses BBB. The male physiology interpretation focuses on the pathway-level detail rather than on any single high-level summary.

Home/ Compounds/ Selank (Intranasal)

Selank (Intranasal)

Men's Health

For men using Selank (Intranasal) in andropause, performance, or recovery contexts, the operating concerns are hormonal coherence, cardiovascular safety, and integration with the broader male-endocrine stack. The compound is delivered at 300 mcg per spray 2-3 sprays daily for 2-4 week courses via intranasal with monitoring centred on the HPG panel. The mechanistic basis is same selank molecule; olfactory pathway bypasses bbb, with downstream effects examined below.

Male Physiology Applications

HPG Axis SupportStrength & PowerAndropauseMuscle MassErectile Function

Key Takeaways

Male-physiology lens: Selank (Intranasal) is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations.
Mechanism: Same Selank molecule; olfactory pathway bypasses BBB.
Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel.
Male dose: 300 mcg per spray 2-3 sprays daily for 2-4 week courses via intranasal; cycle 8-12 weeks.
Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.

Male Physiology Mechanism

Same Selank molecule; olfactory pathway bypasses BBB. For men, the downstream consequences of this mechanism are evaluated against four operational domains: HPG-axis interaction, recovery and body composition, sexual function and prostate, and integration with concurrent TRT or HCG protocols. Selank (Intranasal)'s relationship to each is examined below.

Compatibility with TRT and post-cycle protocols

For men currently on TRT or planning a post-cycle restart, Selank (Intranasal) is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.

Sexual function and prostate considerations

Where Selank (Intranasal) alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.

Male body composition and performance response

Male users typically respond to Selank (Intranasal) on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Same Selank molecule; olfactory pathway bypasses BBB. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.

Male Physiology Applications

Body Composition (Male)

Where male users target body composition (male), Selank (Intranasal) is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Hair Loss

Hair Loss in men responds to Selank (Intranasal) with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.

Muscle Mass

For muscle mass in male users, Selank (Intranasal) is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Sperm Quality

Where male users target sperm quality, Selank (Intranasal) is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	Intranasal	300 mcg per spray	8–12 weeks on / 4 weeks off
Conservative starter	Intranasal	180 mcg per spray	4–6 weeks initial cycle
Men's Health focus	Intranasal	300 mcg per spray	2-3 sprays daily for 2-4 week courses
Maintenance phase	Intranasal	210 mcg per spray	Ongoing with periodic pauses

Dose timing for Selank (Intranasal) is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

Selank (Intranasal) stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.

Selank (Intranasal) + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with Selank (Intranasal)'s mechanism in male physiology protocols.
Selank (Intranasal) + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with Selank (Intranasal)'s mechanism in male physiology protocols.
Selank (Intranasal) + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with Selank (Intranasal)'s mechanism in male physiology protocols.
Selank (Intranasal) + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Selank (Intranasal)'s mechanism in male physiology protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved (Russia approved)

Excellent. Mild nasal irritation possible.

Lens-specific safety considerations for male physiology use of Selank (Intranasal): Excellent. Mild nasal irritation possible. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Selank in GAD

PMID 21443549

Selank (Intranasal) vs Related Peptides

Compound	Profile	Onset	Best For
Selank (Intranasal)	Tuftsin-derived heptapeptide (intranasal)	CNS effect hours	Men's Health
Kisspeptin	Hypothalamic upstream regulator of GnRH	~28 min IV	The upstream master regulator of GnRH neurons — driving the entire HPG axis from above
Gonadorelin (GnRH)	Hypothalamic decapeptide	~2-4 min	The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy
PT-141	Melanocortin receptor agonist	~2-3 hr	An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women

Frequently Asked Questions

Can I use Selank (Intranasal) during a cut?

Yes, and several compounds in this class are specifically protective of lean mass in caloric deficit. The dose-timing relative to training and the protein intake matter more than the absolute dose. Cardiovascular and metabolic monitoring continues to apply.

What blood work should I run on this protocol?

Standard male protocol baseline: total and free testosterone, LH, FSH, estradiol (sensitive), prolactin, SHBG, fasting glucose, HbA1c, hsCRP, lipid panel, CBC, CMP. Follow-up at week 6–8 with the same panel. Add IGF-1 for any GH-axis compound. Add PSA for men over 40.

How does Selank (Intranasal) affect the HPG axis?

Selank (Intranasal)'s effect on the male HPG axis depends on its primary pharmacology. Direct HPG engagement is not the principal mechanism, but indirect effects via inflammation, metabolic status, or hepatic SHBG can produce hormone shifts that warrant baseline and follow-up labs. A comprehensive baseline hormone panel before starting and 6–8 week re-check is the standard approach.

Does Selank (Intranasal) affect hair, prostate, or erythrocyte production?

Where Selank (Intranasal) elevates downstream testosterone or DHT signalling, hair loss in genetically susceptible men is a theoretical consideration; prostate effects and erythrocyte expansion are dose-dependent concerns particularly for men over 40. Routine monitoring (PSA, hematocrit) is appropriate for any protocol producing meaningful androgenic shifts.

Is Selank (Intranasal) safe during pregnancy or breastfeeding?

Selank (Intranasal), like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

How long until I see results from Selank (Intranasal)?

Acute effects from Selank (Intranasal) appear within hours of dosing for receptor-level changes. male hormonal and performance endpoints accumulate across 4–8 weeks; the typical 8–12 week cycle is calibrated to allow the full response window. Single-week evaluations consistently underestimate the response trajectory.

Clinical Protocol

Start a Selank (Intranasal) Protocol

Alukard provides physician-supervised men's health protocols with GMP-certified Selank (Intranasal) and GMP-certified compounds with comprehensive hormone panels.

Get Protocol

Quick Facts

Molecular weight: 751 Da
Sequence length: 7 aa
Half-life: CNS effect hours
WADA: Not on prohibited list
FDA: Unapproved (Russia approved)

Stack Partners

Kisspeptin

Gonadorelin (GnRH)

PT-141

Ipamorelin

CJC-1295 without DAC (Mod GRF 1-29)

Research Note

All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Selank (Intranasal) unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised men's health protocols

Start Your Male Physiology Protocol for Selank (Intranasal)

Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised